Two biotechs to keep an eye on
snippet
Two small biotechs are drawing attention from analysts and investors-Amryt Pharma and Eloxx Pharmaceuticals.
Source
GoinPharma
Headline
Eloxx Receives Another Orphan-Drug Designation for ELX-02
snippet
Eloxx Pharmaceuticals, Inc. (“Eloxx”), (NASDAQ:ELOX), announced on 4/27/18 that it has received orphan-drug designation from the Food and Drug Administration (FDA) for ELX-02 for treatment of cystinosis from the FDA.
Source
CP Wire
Eloxx Receives Another Orphan-Drug Designation for ELX-02
Eloxx Pharmaceuticals, Inc. (“Eloxx”), (NASDAQ:ELOX), announced on 4/27/18 that it has received orphan-drug designation from the Food and Drug Administration (FDA) for ELX-02 for treatment of cystinosis from the FDA.